JPRN-UMIN000027747招募中未知
The effect of Kampo medicine for prevention of chronic subdural hematoma recurrence-prosepective study - The effect of Kampo medicine for prevention of chronic subdural hematoma recurrence-prosepective study
Cerebrovascular Research Institute, Eishokai Yoshida Hospital0 个研究点目标入组 300 人开始时间: 2017年6月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patient with severe dementia 2.Patient unable to take Kampo medicine 3.Bedridden patient
研究者
相似试验
已完成
Unknown
Effects of Kampo medicines on the prevention of COVID-19Coronavirus disease 2019JPRN-UMIN000048389Department of Internal Medicine, Sapporo Suzuki Hospital38
已完成
2 期
Preventive effect of Kampo medicine (Hangeshashin-to) plus Minocycline against afatinib-induced diarrhea, mucositis oral and rash acneiform in patients with non-small cell lung cancer:Multicenter Phase II studyEGFR mutation-positive non-small cell lung cancerJPRN-UMIN000018392ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine28
已完成
不适用
Phase I study of the preventive effect of Kampo medicine on oxaliplatin-induced peripheral neurotoxicitycolorectal cancerJPRN-UMIN000016085Wakayama Medical University, School of Medicine18
招募中
不适用
Camostat Mesilate contained oral wash trialot applicableJPRN-jRCTs031200113ishizaki Yasuriro400
招募中
2 期
Evaluation of the effect of crocin on prevention of atrial fibrillation after heart surgeryParoxysmal atrial fibrillationIRCT20120520009801N4Mashhad University of Medical Sciences80